0000899243-20-017514.txt : 20200623
0000899243-20-017514.hdr.sgml : 20200623
20200623195442
ACCESSION NUMBER: 0000899243-20-017514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200619
FILED AS OF DATE: 20200623
DATE AS OF CHANGE: 20200623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stylli Harry
CENTRAL INDEX KEY: 0001329344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39334
FILM NUMBER: 20983530
MAIL ADDRESS:
STREET 1: 3595 JOHN HOPKINS CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENITY, INC.
CENTRAL INDEX KEY: 0001580063
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 273950390
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 855-293-2639
MAIL ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: ASCENDANT MDX, INC.
DATE OF NAME CHANGE: 20130625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-19
0
0001580063
PROGENITY, INC.
PROG
0001329344
Stylli Harry
C/O PROGENITY, INC.
4330 LA JOLLA VILLAGE DRIVE, SUITE 200
SAN DIEGO
CA
92122
1
1
1
0
Chairman & CEO
Common Stock
2020-06-19
4
P
0
33333
15.00
A
1038635
D
Common Stock
2020-06-23
4
C
0
13213254
A
14251889
D
Common Stock
2020-06-23
4
C
0
202080
A
14453969
D
Series A Preferred Stock
2020-06-23
4
C
0
4120000
0.00
D
Common Stock
13213254
0
D
Series B Preferred Stock
2020-06-23
4
C
0
1122222
0.00
D
Common Stock
202080
0
D
On June 19, 2020, the Reporting Person purchased 33,333 shares of the Issuer's common stock at a price of $15.00 per share in the Issuer's initial public offering.
Includes 239,074 restricted stock units.
The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-3.207 basis immediately prior to the closing of the Issuer's initial public offering.
The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a 0.18007-for-one basis immediately prior to the closing of the Issuer's initial public offering. The conversion rate of the Series B Preferred Stock was adjusted pursuant to the Issuer's seventh amended and restated certificate of incorporation because the public offering price per share of common stock in the Issuer's initial public offering was less than $16.68.
/s/ Clarke Neumann, Attorney-in-Fact for Harry Stylli
2020-06-23